Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases.
Paola GhanemJoseph C MurrayKristen A MarroneSusan C ScottJosephine L FelicianoVincent K LamChristine L HannDavid S EttingerBenjamin P LevyPatrick M FordeAmi A ShahChristopher MecoliJulie BrahmerLaura C CappelliPublished in: RMD open (2023)
Patients with ARD and lung cancer had better OS compared with their counterparts, independent of cancer stage and treatments and were less likely to have advanced stage lung cancer at diagnosis. Additional studies are needed to investigate the differential immunological anti-tumour immune activity and genomic variations in patients with and without ARD.